Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Nuclear Medicine

• Publication date

  2016-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2967/jnumed.115.162032PMID 26541777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

  2015cited by this paper
• Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.

  2015cited by this paper
• PET probes for imaging brain acetylcholinesterase.

  2013cited by this paper
• Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association

  2013cited by this paper
• Butyrylcholinesterase radioligands to image Alzheimer's disease brain.

  2013cited by this paper
• Analytical approaches for monitoring exposure to organophosphorus and carbamate agents through analysis of protein adducts.

  2012cited by this paper
• Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

  2012cited by this paper
• The Nun Study: risk factors for pathology and clinical-pathologic correlations.

  2012cited by this paper
• Synthesis and Preliminary Evaluation of Piperidinyl and Pyrrolidinyl Iodobenzoates as Imaging Agents for Butyrylcholinesterase

  2011cited by this paper
• Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.

  2011cited by this paper
• Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues.

  2010cited by this paper
• Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.

  2008cited by this paper
• Cerebral acetylcholinesterase imaging: development of the radioprobes.

  2007cited by this paper
• In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses

  2006cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography.

  2004cited by this paper
• Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease.

  2004cited by this paper
• Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.

  2003influential reference
• Inhibition of Human Cholinesterases by Drugs Used to Treat Alzheimer Disease

  2003cited by this paper
• Neurobiology of butyrylcholinesterase

  2003cited by this paper
• Butyrylcholinesterase-Mediated Enhancement of the Enzymatic Activity of Trypsin

  2001cited by this paper
• Radiolabeled Cholinesterase Substrates: In Vitro Methods for Determining Structure-Activity Relationships and Identification of a Positron Emission Tomography Radiopharmaceutical for In Vivo Measurement of Butyrylcholinesterase Activity

  2001cited by this paper
• Synthesis of piperidinyl and pyrrolidinyl butyrates for potential In Vivo measurement of cerebral butyrylcholinesterase activity

  2001cited by this paper
• Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity.

  1998cited by this paper
• Protection of a protecting group: Preparation of stable N-silylated t-butyl carbamates

  1997cited by this paper
• Butyrylcholinesterase in the life cycle of amyloid plaques

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.

  1996cited by this paper
• In vivo studies of acetylcholinesterase activity using a labeled substrate, N‐[11C]methylpiperdin‐4‐yl propionate ([11C]PMP)

  1996cited by this paper
• Cholinesterases and the pathology of Alzheimer disease.

  1995cited by this paper
• Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo.

  1994cited by this paper
• Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia

  1994cited by this paper
• Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System

  1986cited by this paper
• CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE

  1978cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Enzyme inhibitors as substrates : interactions of esterases with esters of organophosphorus and carbamic acids

  1972cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Solvents and detergents compatible with enzyme kinetic studies of cholinesterases.

  2023cites this paper
• Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine

  2023cites this paper
• Neuroprotective, Neurite Enhancing and Cholinesterase Inhibitory Effects of Lamiaceae Family Essential Oils in Alzheimer's Disease Model

  2023cites this paper
• Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

  2021cites this paper
• Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase

  2021cites this paper
• Butyrylcholinesterase as a biomarker in Alzheimer’s disease

  2020cites this paper
• Imaging Butyrylcholinesterase in Multiple Sclerosis

  2020cites this paper
• Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus

  2017cites this paper
• Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease

  2017cites this paper
• Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT

  2017cites this paper
• Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease

  2017cites this paper
• Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.

  2016cites this paper